CTI BioPharma

Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Sobi agrees to buy CTI BioPharma for $1.7bn
Pharmaceutical Technology
Thu, 05/11/23 - 09:50 am
Sobi
CTI BioPharma
M&A
hematology
11 drugs granted FDA fast track designation in 2022
Beckers Hospital Review
Wed, 08/24/22 - 10:55 pm
FDA
fast track
Agios Pharmaceuticals
CTI BioPharma
Bristol Myers Squibb
Nobel Biocare
BioXcel Therapeutics
Mycovia Pharmaceuticals
Phathom Pharmaceuticals
Mitsubishi Tanabe Pharma
SIGA technologies
Alnylam Pharmaceuticals
FDA regulatory roundup: two approvals, three rejections & one clinical hold
MedCity News
Sun, 03/6/22 - 11:08 pm
FDA
JNJ
CTI BioPharma
Gilead Sciences
Amryt Pharma
Reata Pharmaceuticals
A new JAK inhibitor earns FDA nod in myelofibrosis, setting up a fight with Incyte, Bristol Myers
Endpoints
Tue, 03/1/22 - 10:35 am
CTI BioPharma
JAK inhibitors
Vonjo
pacritinib
FDA
myelofibrosis
Incyte
Bristol Myers Squibb
Servier acquires lymphoma drug Pixuvri from CTI BioPharma
Pharmaceutical Business Review
Tue, 10/1/19 - 10:50 pm
Pixuvri
Servier
CTI BioPharma
M&A
lymphoma
Shire bids CTI and its troubled myelofibrosis drug adieu, buying its way out of a deal
Endpoints
Tue, 10/25/16 - 09:54 am
Shire
myelofibrosis
CTI BioPharma
Baxalta
M&A
pacritinib
Shire wants out of that $172M Baxalta deal with CTI Bio
Endpoints
Mon, 09/19/16 - 06:03 pm
Shire
Baxalta
CTI BioPharma
M&A
4 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Tue, 02/16/16 - 09:58 am
CTI BioPharma
Incyte
Biocryst
NxStage Medical
FDA puts full clinical hold on CTI BioPharma's blood cancer drug
Yahoo/Reuters
Wed, 02/10/16 - 03:21 pm
CTI BioPharma
FDA
blood cancer
pacritinib
Baxalta drops, CTI nosedives after patient deaths & adverse events prompt FDA partial hold
BioPharma Dive
Mon, 02/8/16 - 10:24 am
Baxalta
Shire
CTI BioPharma
pacritinib
JAK inhibitors
Three Small Companies With Big Name Partnerships In Immuno-Oncology
Yahoo
Tue, 12/1/15 - 02:41 pm
immuno-oncology
Peregrine Pharmaceuticals
AstraZenca
MabVax Therapeutics
Juno Therapeutics
CTI BioPharma
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer
24/7 Wall St
Sun, 06/7/15 - 10:07 am
biotech
ASCO
Immunogen
Exelixis
Oncothyreon
CTI BioPharma
Immunomedics
Vascular Biogenics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
ASCO
Oncothyreon
Immunogen
Bristol-Myers Squibb
Merck
Clovis Oncology
Roche
CTI BioPharma
Celldex Therapeutics
Puma Biotechnology
Express Scripts
6 Key Cancer Winners From ASCO Presentations
24/7 Wall St
Mon, 06/1/15 - 10:06 am
ASCO
Immunogen
mirevtuximab soravtansine
ONT-380
Oncothyreon
cabozantinib
Exelixis
VB-111
Vascular Biogenics
Immunomedics
sacituzumab govitecan
pacritinib
CTI BioPharma
ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival
TheStreet.com
Sat, 05/30/15 - 05:44 pm
ASCO
CTI BioPharma
myelofibrosis
pacritinib
Jakafi
Incyte
Baxter and its controversial partner CTI claim a win in PhIII blood cancer study
Fierce Biotech
Mon, 03/9/15 - 08:47 am
Baxter
CTI BioPharma
pacritinib
myelofibrosis
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
TheStreet.com
Wed, 12/17/14 - 10:02 am
Biogen Idec
Bluebird Bio
Arrowhead Research
Vertex Pharmaceuticals
Cempra
CTI BioPharma
Gilead Sciences
Merck
Bristol-Myers Squibb
Sarepta Therapeutics
Neurocrine Biosciences

Pages